2023 Q1 Form 10-K Financial Statement

#000155335023000172 Filed on March 17, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $2.079M $2.114M $8.157M
YoY Change 10.42% 6.42%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $978.8K $860.0K $3.824M
YoY Change -0.22%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $6.257K $6.180K $22.28K
YoY Change 37.79% -35.75%
% of Gross Profit
Operating Expenses $1.207M $1.089M $4.816M
YoY Change 1.34%
Operating Profit
YoY Change
Interest Expense $791.6K -$774.9K $2.328M
YoY Change 85.62% 34.9%
% of Operating Profit
Other Income/Expense, Net $27.47K $181.8K
YoY Change -37.34% 8.98%
Pretax Income $79.75K $249.6K $1.012M
YoY Change -73.48% -14.67%
Income Tax $10.87K $8.600K $206.2K
% Of Pretax Income 13.63% 3.45% 20.37%
Net Earnings $68.88K $211.9K $806.1K
YoY Change -69.4% -8.01%
Net Earnings / Revenue 3.31% 10.03% 9.88%
Basic Earnings Per Share $0.01 $0.25
Diluted Earnings Per Share $0.01 $0.06 $0.21
COMMON SHARES
Basic Shares Outstanding 2.905M shares 2.905M shares 2.905M shares
Diluted Shares Outstanding 3.357M shares 3.408M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $260.5K $421.2K $421.2K
YoY Change 1906.72%
Cash & Equivalents $260.5K $421.2K
Short-Term Investments
Other Short-Term Assets $349.8K $348.8K $348.8K
YoY Change -35.18%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $52.63M $50.24M $50.24M
YoY Change 6.38% 6.38%
LONG-TERM ASSETS
Property, Plant & Equipment $97.33K $103.6K $351.9K
YoY Change 23.63% -6.88%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $915.5K $892.0K $892.0K
YoY Change -1.64%
Total Long-Term Assets $1.230M $1.244M $1.244M
YoY Change -3.18% -3.18%
TOTAL ASSETS
Total Short-Term Assets $52.63M $50.24M $50.24M
Total Long-Term Assets $1.230M $1.244M $1.244M
Total Assets $53.86M $51.49M $51.49M
YoY Change 6.12% 6.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $1.564M $1.440M $1.440M
YoY Change -10.95%
Deferred Revenue
YoY Change
Short-Term Debt $37.00M $34.54M $34.54M
YoY Change 6.07%
Long-Term Debt Due $932.7K $1.554M $1.554M
YoY Change -54.69%
Total Short-Term Liabilities $39.49M $37.54M $37.54M
YoY Change -0.2% -0.2%
LONG-TERM LIABILITIES
Long-Term Debt $8.308M $7.927M $7.927M
YoY Change 26.89%
Other Long-Term Liabilities $57.91K $73.85K $73.85K
YoY Change -40.48%
Total Long-Term Liabilities $8.366M $8.001M $8.001M
YoY Change 25.58% 25.58%
TOTAL LIABILITIES
Total Short-Term Liabilities $39.49M $37.54M $37.54M
Total Long-Term Liabilities $8.366M $8.001M $8.001M
Total Liabilities $47.86M $45.54M $45.54M
YoY Change 3.53% 3.53%
SHAREHOLDERS EQUITY
Retained Earnings $2.606M $2.566M
YoY Change 38.78%
Common Stock $2.905K $2.905K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.999M $5.952M $5.952M
YoY Change
Total Liabilities & Shareholders Equity $53.86M $51.49M $51.49M
YoY Change 6.12% 6.12%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income $68.88K $211.9K $806.1K
YoY Change -69.4% -8.01%
Depreciation, Depletion And Amortization $6.257K $6.180K $22.28K
YoY Change 37.79% -35.75%
Cash From Operating Activities $934.9K -$47.32K $1.625M
YoY Change -23.45% -21.36%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $23.95K $48.75K
YoY Change -100.0% 32.0%
Acquisitions
YoY Change
Other Investing Activities -$2.742M $3.097M -$3.574M
YoY Change -58.25%
Cash From Investing Activities -$2.742M $3.074M -$3.623M
YoY Change 10.01% -57.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $1.647M -2.702M $2.398M
YoY Change 21.31% -60.52%
NET CHANGE
Cash From Operating Activities $934.9K -47.32K $1.625M
Cash From Investing Activities -$2.742M 3.074M -$3.623M
Cash From Financing Activities $1.647M -2.702M $2.398M
Net Change In Cash -$160.7K 324.4K $400.2K
YoY Change -287.1% -187.71%
FREE CASH FLOW
Cash From Operating Activities $934.9K -$47.32K $1.625M
Capital Expenditures $0.00 $23.95K $48.75K
Free Cash Flow $934.9K -$71.27K $1.576M
YoY Change -21.86% -22.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001807893
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
000-56243
CY2022 dei Entity Registrant Name
EntityRegistrantName
Standard Premium Finance Holdings, Inc.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-2624094
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
13590 SW 134th Avenue
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 214
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Miami
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33186
CY2022 dei City Area Code
CityAreaCode
305
CY2022 dei Local Phone Number
LocalPhoneNumber
232-2752
CY2022 dei Security12g Title
Security12gTitle
Common Stock, $.001 par value per share
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
6667601 usd
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2905016 shares
CY2022 dei Auditor Name
AuditorName
Assurance Dimensions
CY2022 dei Auditor Location
AuditorLocation
Margate, Florida
CY2022 dei Auditor Firm
AuditorFirmId
5036
CY2022Q4 us-gaap Cash
Cash
421211 usd
CY2021Q4 us-gaap Cash
Cash
20987 usd
CY2022Q4 spfx Premium Finance Contracts And Related Receivable Net
PremiumFinanceContractsAndRelatedReceivableNet
49474903 usd
CY2021Q4 spfx Premium Finance Contracts And Related Receivable Net
PremiumFinanceContractsAndRelatedReceivableNet
46674273 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
196407 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
228954 usd
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
51920 usd
CY2021Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
65176 usd
CY2022Q4 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
603816 usd
CY2021Q4 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
559877 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
348795 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
538139 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
50244909 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
47233399 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
103591 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
83794 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
288164 usd
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
347000 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
891980 usd
CY2021Q4 us-gaap Other Assets
OtherAssets
906877 usd
CY2022Q4 us-gaap Assets
Assets
51488807 usd
CY2021Q4 us-gaap Assets
Assets
48518200 usd
CY2022Q4 us-gaap Bank Overdrafts
BankOverdrafts
0 usd
CY2021Q4 us-gaap Bank Overdrafts
BankOverdrafts
153264 usd
CY2022Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
32713625 usd
CY2021Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
30476375 usd
CY2022Q4 srt Drafts Payable
DraftsPayable
1827884 usd
CY2021Q4 srt Drafts Payable
DraftsPayable
1935278 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
1340597 usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
2285023 usd
CY2022Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
109000 usd
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
862000 usd
CY2022Q4 spfx Payroll Protection Program Loan Current Portion
PayrollProtectionProgramLoanCurrentPortion
91852 usd
CY2021Q4 spfx Payroll Protection Program Loan Current Portion
PayrollProtectionProgramLoanCurrentPortion
271000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
122554 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
104880 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
12494 usd
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
11857 usd
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1317699 usd
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1512528 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
37535705 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
37612205 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
5946324 usd
CY2021Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
4964787 usd
CY2022Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
1816000 usd
CY2021Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
1229302 usd
CY2022Q4 spfx Payroll Protection Program Loan Net Of Current Portion
PayrollProtectionProgramLoanNetOfCurrentPortion
123924 usd
CY2021Q4 spfx Payroll Protection Program Loan Net Of Current Portion
PayrollProtectionProgramLoanNetOfCurrentPortion
0 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
73853 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
124074 usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
40559 usd
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
53053 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
8000660 usd
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
6371216 usd
CY2022Q4 us-gaap Liabilities
Liabilities
45536365 usd
CY2021Q4 us-gaap Liabilities
Liabilities
43983421 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.28
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.21
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.28
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2905016 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2905016 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2905016 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2905016 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
2905 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
2905 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3383651 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2682995 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2565720 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1848780 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
5952442 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
4534779 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
51488807 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
48518200 usd
CY2022 us-gaap Revenues
Revenues
8156537 usd
CY2021 us-gaap Revenues
Revenues
7664743 usd
CY2022 us-gaap Interest Expense
InterestExpense
2328004 usd
CY2021 us-gaap Interest Expense
InterestExpense
1725745 usd
CY2022 us-gaap Salaries And Wages
SalariesAndWages
1557223 usd
CY2021 us-gaap Salaries And Wages
SalariesAndWages
1471547 usd
CY2022 us-gaap Leasing Commissions Expense
LeasingCommissionsExpense
976990 usd
CY2021 us-gaap Leasing Commissions Expense
LeasingCommissionsExpense
1001945 usd
CY2022 spfx Bad Debts
BadDebts
734040 usd
CY2021 spfx Bad Debts
BadDebts
842019 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
374144 usd
CY2021 us-gaap Professional Fees
ProfessionalFees
350145 usd
CY2022 us-gaap Postage Expense
PostageExpense
110752 usd
CY2021 us-gaap Postage Expense
PostageExpense
111242 usd
CY2022 us-gaap Other Expenses
OtherExpenses
181787 usd
CY2021 us-gaap Other Expenses
OtherExpenses
166810 usd
CY2022 us-gaap Other General Expense
OtherGeneralExpense
881276 usd
CY2021 us-gaap Other General Expense
OtherGeneralExpense
808960 usd
CY2022 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
7144216 usd
CY2021 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
6478413 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1012321 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1186330 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
206190 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
310007 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
806131 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
876323 usd
CY2022 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
89191 usd
CY2021 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
69300 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
716940 usd
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
807023 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
CY2021 us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
153264 usd
CY2022 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
2167052 usd
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2905016 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2905016 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3407949 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2905016 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
3683812 usd
CY2021 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
43944 usd
CY2021 spfx Dividends Paid On Preferred Stock
DividendsPaidOnPreferredStock
-69300 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
876323 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
4534779 usd
CY2022 spfx Series A Convertible Preferred Stock Issued For Cash
SeriesAConvertiblePreferredStockIssuedForCash
400000 usd
CY2022 spfx Series A Convertible Preferred Stock Issued In Exchange For Note Payable
SeriesAConvertiblePreferredStockIssuedInExchangeForNotePayable
270000 usd
CY2022 spfx Warrants Issued For Services
WarrantsIssuedForServices
10800 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
19878 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
45 usd
CY2022 spfx Dividends Paid On Preferred Stock
DividendsPaidOnPreferredStock
-89191 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
806131 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
5952442 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
806131 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
876323 usd
CY2022 us-gaap Depreciation
Depreciation
22283 usd
CY2021 us-gaap Depreciation
Depreciation
34682 usd
CY2022 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-2167 usd
CY2021 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-0 usd
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
103585 usd
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
101806 usd
CY2022 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
13256 usd
CY2021 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
625 usd
CY2022 spfx Bad Debt Expense
BadDebtExpense
734040 usd
CY2021 spfx Bad Debt Expense
BadDebtExpense
842019 usd
CY2022 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
-70198 usd
CY2021 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
-142980 usd
CY2022 spfx Options Issued For Services
OptionsIssuedForServices
19878 usd
CY2021 spfx Options Issued For Services
OptionsIssuedForServices
34669 usd
CY2022 us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
10800 usd
CY2021 us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
9275 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-189344 usd
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
154231 usd
CY2022 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-58836 usd
CY2021 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
87000 usd
CY2022 us-gaap Increase Decrease In Book Overdrafts
IncreaseDecreaseInBookOverdrafts
-107394 usd
CY2021 us-gaap Increase Decrease In Book Overdrafts
IncreaseDecreaseInBookOverdrafts
64313 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-194829 usd
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
302267 usd
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-103585 usd
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-101806 usd
CY2021 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
4679922 usd
CY2022 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
575511 usd
CY2021 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1246047 usd
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
288400 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1624710 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2065922 usd
CY2022 spfx Disbursements Under Premium Finance Contracts Receivable Net
DisbursementsUnderPremiumFinanceContractsReceivableNet
3534670 usd
CY2021 spfx Disbursements Under Premium Finance Contracts Receivable Net
DisbursementsUnderPremiumFinanceContractsReceivableNet
8516366 usd
CY2022 us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
43939 usd
CY2021 us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
43571 usd
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
4500 usd
CY2021 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
48747 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
36929 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3622856 usd
CY2021 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
77400 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8596866 usd
CY2022 us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
-153264 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
35000 usd
CY2021 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
168000 usd
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
181302 usd
CY2021 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
25000 usd
CY2022 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
11857 usd
CY2021 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
891 usd
CY2022 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
400000 usd
CY2021 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
0 usd
CY2022 spfx Repayment Of Ppp Loan
RepaymentOfPppLoan
55224 usd
CY2021 spfx Repayment Of Ppp Loan
RepaymentOfPppLoan
-0 usd
CY2022 us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
45 usd
CY2021 us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
0 usd
CY2022 spfx Dividend Distributions Paid
DividendDistributionsPaid
89191 usd
CY2021 spfx Dividend Distributions Paid
DividendDistributionsPaid
69300 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2398370 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6074642 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
400224 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-456302 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20987 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
477289 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
421211 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20987 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
395240 usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
365248 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
2201574 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
1731968 usd
CY2022 spfx Debt Exchanged For Series Convertible Preferred Stock
DebtExchangedForSeriesConvertiblePreferredStock
270000 usd
CY2021 spfx Debt Exchanged For Series Convertible Preferred Stock
DebtExchangedForSeriesConvertiblePreferredStock
0 usd
CY2022 spfx Operating Lease Asset Obtained In Exchange For Operating Lease Liability
OperatingLeaseAssetObtainedInExchangeForOperatingLeaseLiability
71038 usd
CY2021 spfx Operating Lease Asset Obtained In Exchange For Operating Lease Liability
OperatingLeaseAssetObtainedInExchangeForOperatingLeaseLiability
235335 usd
CY2022 spfx Finance Lease Assets Obtained In Exchange For Lease Liabilities
FinanceLeaseAssetsObtainedInExchangeForLeaseLiabilities
0 usd
CY2021 spfx Finance Lease Assets Obtained In Exchange For Lease Liabilities
FinanceLeaseAssetsObtainedInExchangeForLeaseLiabilities
65801 usd
CY2022Q4 spfx Plus Cash Overdraft
PlusCashOverdraft
0 usd
CY2021Q4 spfx Plus Cash Overdraft
PlusCashOverdraft
153264 usd
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2021Q4 us-gaap Bank Overdrafts
BankOverdrafts
153264 usd
CY2022Q4 us-gaap Unearned Premiums
UnearnedPremiums
71315354 usd
CY2021Q4 us-gaap Unearned Premiums
UnearnedPremiums
67929695 usd
CY2022 us-gaap Debt Instrument Interest Rate Increase Decrease
DebtInstrumentInterestRateIncreaseDecrease
0.153 pure
CY2021 us-gaap Debt Instrument Interest Rate Increase Decrease
DebtInstrumentInterestRateIncreaseDecrease
0.154 pure
CY2021Q4 spfx Plus Balances At Other Institutions That Do Not Exceed Fdic Limit
PlusBalancesAtOtherInstitutionsThatDoNotExceedFdicLimit
193179 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84F_eus-gaap--UseOfEstimates_zOl9Ef5CYDI4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_865_ziRRrL2DHwYz">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include assumptions used in valuation of deferred tax assets, allowance for doubtful accounts, depreciable lives of property and equipment, and valuation of stock-based compensation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_843_eus-gaap--ConcentrationRiskCreditRisk_zpWPuBGIuamH" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86F_zm6Eeffitk8y">Concentration of Credit and Financial Instrument Risk</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk are primarily cash and accounts receivable from customers, agents, and insurance companies. The Company maintains its cash balances at two banks. Accounts at this financial institution are insured by the Federal Deposit Insurance Corporation up to $<span id="xdx_90E_eus-gaap--CashFDICInsuredAmount_c20221231_pp0p0_zE0P6su5Od7k" title="FDIC insured amount">250,000</span>. Uninsured balances are approximately $<span id="xdx_900_eus-gaap--CashUninsuredAmount_c20221231_pp0p0_z8bfxkKVEdSO" title="Uninsured balances">482,479</span> and $<span id="xdx_907_eus-gaap--CashUninsuredAmount_c20211231_pp0p0_zywng1Hb1nRm" title="Uninsured balances">0</span> at December 31, 2022 and 2021, respectively. The Company mitigates this risk by maintaining its cash balances at a high-quality financial institution. The following table provides a reconciliation between uninsured balances and cash per the consolidated balance sheet:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_883_ecustom--SchedulesOfReconciliationBetweenUninsuredBalancesAndCashTextBlock_z9CuuHaOtNI2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details)"> <tr style="vertical-align: bottom; background-color: transparent"> <td style="text-align: justify"><span id="xdx_8BF_zYKzLXsykrp_zSo7oIZGSUuk" style="display: none">Schedule of reconciliation between uninsured balances and cash per the balance sheet</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_497_20221231_zsvlQoOaCn5_znJ6yqGK4i27" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_491_20211231_z3YxDBtqU8vV" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 11pt; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">December 31, <br/> 2022</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td></tr> <tr id="xdx_40F_eus-gaap--CashUninsuredAmount_iI_pp0p0_d0_zS0oqN4L21Lp" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="width: 74%; text-align: justify">Uninsured Balance</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">482,479</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">—</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_ecustom--PlusInsuredBalances_iI_pp0p0_d0_zu3IYTa8R1Oh" style="vertical-align: bottom; background-color: transparent"> <td style="text-align: justify">Plus: Insured balances</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">250,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--PlusBalancesAtOtherInstitutionsThatDoNotExceedFdicLimit_iI_pp0p0_z2HtZvWNqTBq" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-align: justify">Plus: Balances at other institutions that do not exceed FDIC limit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17,758</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">193,179</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_ecustom--PlusCashOverdraft_iI_pp0p0_d0_zpYwxX0LM8Wf" style="vertical-align: bottom; background-color: transparent"> <td style="text-align: justify">Plus: Cash overdraft</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">153,264</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--OutstandingChecks_iI_pp0p0_z2PERBGMdUEz" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-align: justify">Less: Outstanding checks</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(329,026</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(325,456</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font-size: 11pt; text-align: justify; padding-bottom: 1pt"> </td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: right"> </td><td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: right"> </td><td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--Cash_iI_pp0p0_zVIXa6NmYuog" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="padding-bottom: 2.5pt; text-align: justify">Cash per Consolidated Balance Sheet</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">421,211</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">20,987</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company controls its credit risk in accounts receivable through credit standards, limits on exposure, by monitoring the financial condition of insurance companies, by adhering to statutory cancellation policies, and by monitoring and pursuing collections from past due accounts. We cancel policies at the earliest permissible date allowed by the statutory cancellation regulations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Approximately <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__srt--StatementGeographicalAxis__stpr--FL_zHZ2ukDUzh5E" title="Concentration risk percentage">59</span>% and <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__srt--StatementGeographicalAxis__stpr--FL_zXDwelAUhWYR" title="Concentration risk percentage">53</span>% of the Company’s business activity is with customers located in Florida for 2022 and 2021, respectively. Approximately <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__srt--StatementGeographicalAxis__stpr--GA_zLYvDKuGnFUU" title="Concentration risk percentage">12</span>% and <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__srt--StatementGeographicalAxis__stpr--GA_zioVtAhfMqpS" title="Concentration risk percentage">19</span>% of the Company’s business activity is with customers located in Georgia for 2022 and 2021, respectively. Approximately <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__srt--StatementGeographicalAxis__stpr--NC_z2PlDNqlriMq" title="Concentration risk percentage">12</span>% and <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__srt--StatementGeographicalAxis__stpr--NC_zJ58n2SJbThC" title="Concentration risk percentage">13</span>% of the Company’s business activity is with customers located in North Carolina for 2022 and 2021, respectively. There were no other significant regional, industrial or group concentrations during the years ended December 31, 2022 and 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2022Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2022Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
482479 usd
CY2021Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
0 usd
CY2022Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
482479 usd
CY2021Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
0 usd
CY2022Q4 spfx Plus Insured Balances
PlusInsuredBalances
250000 usd
CY2021Q4 spfx Plus Insured Balances
PlusInsuredBalances
0 usd
CY2022Q4 spfx Plus Balances At Other Institutions That Do Not Exceed Fdic Limit
PlusBalancesAtOtherInstitutionsThatDoNotExceedFdicLimit
17758 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
20000 shares
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1035000 shares
CY2022Q4 spfx Outstanding Checks
OutstandingChecks
-329026 usd
CY2021Q4 spfx Outstanding Checks
OutstandingChecks
-325456 usd
CY2022Q4 us-gaap Cash
Cash
421211 usd
CY2021Q4 us-gaap Cash
Cash
20987 usd
CY2022Q4 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
603816 usd
CY2021Q4 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
559877 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2022Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 usd
CY2021Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
207400 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
187400 shares
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
187400 shares
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
975000 shares
CY2022Q4 spfx Insurance Premium Finance Contracts Outstanding
InsurancePremiumFinanceContractsOutstanding
45520349 usd
CY2021Q4 spfx Insurance Premium Finance Contracts Outstanding
InsurancePremiumFinanceContractsOutstanding
44079251 usd
CY2022Q4 spfx Insurance Premium Finance Contracts Cancelled
InsurancePremiumFinanceContractsCancelled
6005601 usd
CY2021Q4 spfx Insurance Premium Finance Contracts Cancelled
InsurancePremiumFinanceContractsCancelled
4426576 usd
CY2022Q4 spfx Insurance Premium Finance Contracts Gross
InsurancePremiumFinanceContractsGross
51525950 usd
CY2021Q4 spfx Insurance Premium Finance Contracts Gross
InsurancePremiumFinanceContractsGross
48505827 usd
CY2022Q4 spfx Amounts Due From Agents
AmountsDueFromAgents
645648 usd
CY2021Q4 spfx Amounts Due From Agents
AmountsDueFromAgents
793869 usd
CY2022Q4 spfx Present Value Of Lease Liabilities
PresentValueOfLeaseLiabilities
249460 usd
CY2022Q4 spfx Unearned Interest
UnearnedInterest
-1567197 usd
CY2021Q4 spfx Unearned Interest
UnearnedInterest
-1431666 usd
CY2022Q4 spfx Insurance Premium Finance Contracts Net
InsurancePremiumFinanceContractsNet
50604401 usd
CY2021Q4 spfx Insurance Premium Finance Contracts Net
InsurancePremiumFinanceContractsNet
47868030 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1129498 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1193757 usd
CY2022Q4 spfx Premium Finance Contracts And Related Receivable Net
PremiumFinanceContractsAndRelatedReceivableNet
49474903 usd
CY2021Q4 spfx Premium Finance Contracts And Related Receivable Net
PremiumFinanceContractsAndRelatedReceivableNet
46674273 usd
CY2022Q4 spfx Allowance For Premium Finance Contracts
AllowanceForPremiumFinanceContracts
1000000 usd
CY2021Q4 spfx Allowance For Premium Finance Contracts
AllowanceForPremiumFinanceContracts
1000000 usd
CY2022Q4 spfx Allowance For Amounts Due From Agents
AllowanceForAmountsDueFromAgents
129498 usd
CY2021Q4 spfx Allowance For Amounts Due From Agents
AllowanceForAmountsDueFromAgents
193757 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1129498 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1193757 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1193757 usd
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
824342 usd
CY2022 spfx Current Year Provision
CurrentYearProvision
1347475 usd
CY2021 spfx Current Year Provision
CurrentYearProvision
1353057 usd
CY2022 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1513814 usd
CY2021 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1212150 usd
CY2022 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
102080 usd
CY2021 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
228508 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1129498 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1193757 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
68308 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
45918 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
13879 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
266214 usd
CY2022 spfx Total Provision
TotalProvision
1347475 usd
CY2021 spfx Total Provision
TotalProvision
1353057 usd
CY2022 spfx Contra Rrevenues
ContraRrevenues
-613435 usd
CY2021 spfx Contra Rrevenues
ContraRrevenues
-483746 usd
CY2022 spfx Current Year Provisions For Amounts Due From Agents
CurrentYearProvisionsForAmountsDueFromAgents
-0 usd
CY2021 spfx Current Year Provisions For Amounts Due From Agents
CurrentYearProvisionsForAmountsDueFromAgents
27292 usd
CY2022 spfx Bad Debt Expense
BadDebtExpense
734040 usd
CY2021 spfx Bad Debt Expense
BadDebtExpense
842019 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
348399 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
308132 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
244808 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
224338 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
103591 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
83794 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
22283 usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
34682 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
138109 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
16754 usd
CY2022Q4 us-gaap Other Notes Payable
OtherNotesPayable
215776 usd
CY2021Q4 us-gaap Other Notes Payable
OtherNotesPayable
271000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
196407 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
228954 usd
CY2022Q4 spfx Server Lease
ServerLease
51920 usd
CY2021Q4 spfx Server Lease
ServerLease
65176 usd
CY2022Q4 spfx Total Lease Assets
TotalLeaseAssets
248327 usd
CY2021Q4 spfx Total Lease Assets
TotalLeaseAssets
294130 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
122554 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
104880 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
73853 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
124074 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
196407 usd
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
228954 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
12494 usd
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
11857 usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
40559 usd
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
53053 usd
CY2022Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
53053 usd
CY2021Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
64910 usd
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y4M24D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y11M26D
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
114086 usd
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
113577 usd
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
97978 usd
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
97978 usd
CY2022Q4 srt Drafts Payable
DraftsPayable
1827884 usd
CY2021Q4 srt Drafts Payable
DraftsPayable
1935278 usd
CY2022Q4 us-gaap Line Of Credit Facility Collateral Fees Amount
LineOfCreditFacilityCollateralFeesAmount
25771 usd
CY2022Q4 us-gaap Line Of Credit Facility Collateral Fees Amount
LineOfCreditFacilityCollateralFeesAmount
117228 usd
CY2022Q2 us-gaap Interest Payable Current
InterestPayableCurrent
7801 usd
CY2022Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
91852 usd
CY2021Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
1229302 usd
CY2021Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
271000 usd
CY2022Q4 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
123924 usd
CY2021Q4 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
0 usd
CY2022Q4 us-gaap Notes Payable
NotesPayable
2441523 usd
CY2021Q4 us-gaap Notes Payable
NotesPayable
2574404 usd
CY2022 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
507000 usd
CY2021 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
475000 usd
CY2022 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
575511 usd
CY2021 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1246047 usd
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
288400 usd
CY2021 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
77400 usd
CY2022Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
250000 usd
CY2022Q2 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
25000 shares
CY2022Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
10.00
CY2022Q4 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
1925000 usd
CY2021Q4 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
2091302 usd
CY2022Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
109000 usd
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
862000 usd
CY2022Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
1816000 usd
CY2022Q4 spfx Notes Payables
NotesPayables
862000 usd
CY2021Q4 spfx Notes Payables
NotesPayables
424301 usd
CY2022 us-gaap Interest Expense Other
InterestExpenseOther
156000 usd
CY2021 us-gaap Interest Expense Other
InterestExpenseOther
170000 usd
CY2022 us-gaap Proceeds From Secured Notes Payable
ProceedsFromSecuredNotesPayable
35000 usd
CY2021 us-gaap Proceeds From Secured Notes Payable
ProceedsFromSecuredNotesPayable
168000 usd
CY2022 spfx Repayments Of Other Notes Payable
RepaymentsOfOtherNotesPayable
181302 usd
CY2021 spfx Repayments Of Other Notes Payable
RepaymentsOfOtherNotesPayable
25000 usd
CY2022Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
10.00
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
256841 usd
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
303634 usd
CY2022 spfx Temporary Differences
TemporaryDifferences
-57772 usd
CY2021 spfx Temporary Differences
TemporaryDifferences
-2167 usd
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
7121 usd
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
8540 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
0 usd
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
0 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
206190 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
310007 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.2100 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.2100 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements State And Local
EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal
0.0437 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements State And Local
EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal
0.0459 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.0070 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.0072 pure
CY2022 spfx Change In Temporary Differences
ChangeInTemporaryDifferences
-0.0571 pure
CY2021 spfx Change In Temporary Differences
ChangeInTemporaryDifferences
-0.0018 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.0000 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.0000 pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.2036 pure
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.2613 pure
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
253715 usd
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
291400 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
11257 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
16300 usd
CY2022Q4 spfx Book To Tax Depreciation
BookToTaxDepreciation
23192 usd
CY2021Q4 spfx Book To Tax Depreciation
BookToTaxDepreciation
39300 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
288164 usd
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
347000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
288164 usd
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
347000 usd
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y1M24D
CY2022Q4 spfx Designated Shares
DesignatedShares
600000 shares
CY2021Q4 spfx Designated Shares
DesignatedShares
600000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
166000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
166000 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
99000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
99000 shares
CY2022Q4 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
10
CY2022Q4 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
1689050 usd
CY2022Q4 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
10
CY2022 us-gaap Dividends
Dividends
89191 usd
CY2021 us-gaap Dividends
Dividends
69300 usd
CY2022Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
29050 usd
CY2021Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
17325 usd
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2905016 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2905016 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2905016 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2905016 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
207400 shares
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y1M24D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.18
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
187400 shares
CY2022 spfx Sharesbased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharesbasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y2M1D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
0.80
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
187400 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.80
CY2020 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P9Y2M12D
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
0 shares
CY2021 spfx Weighted Average Exercise Price Options Issued
WeightedAverageExercisePriceOptionsIssued
0
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
187400 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.80
CY2021 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P8Y2M12D
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
20000 shares
CY2022 spfx Weighted Average Exercise Price Options Issued
WeightedAverageExercisePriceOptionsIssued
4.73
CY2022 spfx Sharebased Compensation Arrangement By Sharebased Payment Award Options Issued Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsIssuedWeightedAverageRemainingContractualTerm1
P7Y6M
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
207400 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.18
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1091236 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
187400 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.80
CY2022 spfx Sharesbased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharesbasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P7Y2M1D
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1056936 usd
CY2022 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
19878 usd
CY2021 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
34669 usd
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
800000 shares
CY2020Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
8.00
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P4Y3M18D
CY2021 spfx Warrants Issued
WarrantsIssued
175000 shares
CY2021 spfx Weighted Average Exercise Price Issued
WeightedAverageExercisePriceIssued
4.00
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
0 shares
CY2021 spfx Share Based Compensation Arrangements By Share Based Payment Award Other Than Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
975000 shares
CY2021Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
7.28
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P3Y6M
CY2022 spfx Warrants Issued
WarrantsIssued
60000 shares
CY2022 spfx Weighted Average Exercise Price Issued
WeightedAverageExercisePriceIssued
4.00
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
0 shares
CY2022 spfx Share Based Compensation Arrangements By Share Based Payment Award Other Than Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1035000 shares
CY2022Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
7.09
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P2Y7M6D
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
1549400 usd
CY2022Q4 spfx Warrants Exercisable
WarrantsExercisable
1035000 shares
CY2022Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
7.09
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P2Y7M6D
CY2022Q4 spfx Sharebased Compensation Arrangement By Sharebased Payment Award Otherthan Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOtherthanOptionsExercisableIntrinsicValue1
1549400 usd
CY2022Q2 spfx Warrant Issued For Services
WarrantIssuedForServices
10800 usd
CY2021Q2 spfx Warrant Issued For Services
WarrantIssuedForServices
9275 usd
CY2020Q2 spfx Warrant Issued For Services
WarrantIssuedForServices
27200 usd
CY2022 spfx Stock Warrant Expense
StockWarrantExpense
10800 usd
CY2021 spfx Stock Warrant Expense
StockWarrantExpense
9275 usd
CY2022 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
50000 usd
CY2021 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
75000 usd
CY2022 us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2025-11-30
CY2022Q4 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
1925000 usd
CY2021Q4 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
2091302 usd

Files In Submission

Name View Source Status
0001553350-23-000172-index-headers.html Edgar Link pending
0001553350-23-000172-index.html Edgar Link pending
0001553350-23-000172.txt Edgar Link pending
0001553350-23-000172-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.gif Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
spfx-20221231_cal.xml Edgar Link unprocessable
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
spfh_10k.htm Edgar Link pending
spfh_ex31z1.htm Edgar Link pending
spfh_ex31z2.htm Edgar Link pending
spfh_ex32z1.htm Edgar Link pending
spfx-20221231.xsd Edgar Link pending
spfh_10k_htm.xml Edgar Link completed
spfx_ex10z10.htm Edgar Link pending
spfx_ex10z7.htm Edgar Link pending
spfx_ex10z9.htm Edgar Link pending
spfx_ex4z1.htm Edgar Link pending
spfx-20221231_def.xml Edgar Link unprocessable
spfx-20221231_lab.xml Edgar Link unprocessable
spfx-20221231_pre.xml Edgar Link unprocessable